<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05029362</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-SPH-20-0318</org_study_id>
    <nct_id>NCT05029362</nct_id>
  </id_info>
  <brief_title>SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups</brief_title>
  <official_title>SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to pretest the design of a text-based smoking cessation program&#xD;
      tailored to sexual minority individuals.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceived usability as assessed by the System Usability Scale (SUS)</measure>
    <time_frame>1 month after quit date</time_frame>
    <description>Participants will rank each of the 10 questions for usability from 1 to 5, based on their level of agreement (1 for Strongly Disagree to 5 for Strongly Agree). After computing the usability score, we will convert it to percentile ranks. A percentile rank of 75% will indicate that the text-based smoking cessation program has a high perceived usability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Engagement as assessed by the Number of text messages sent and received by study participants after enrollment.</measure>
    <time_frame>1 month after enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Beta testing group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SmokefreeSGM</intervention_name>
    <description>Participants will have access to a text-based smoking cessation program tailored to sexual minority individuals (SmokefreeSGM). The text-based program will be beta-tested by these participants for a period of 2 weeks before and 10 weeks after their quit date. Messages originated from the text-based smoking cessation program will be sent by a fictitious quit coach who will offer evidence-based advice on quitting smoking based on real-life experiences of sexual minority individuals.</description>
    <arm_group_label>Beta testing group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Smoke five or more cigarettes per day&#xD;
&#xD;
          -  Have an interest in quitting smoking in the next 15 days&#xD;
&#xD;
          -  Have a cellphone number with an unlimited short messaging service (SMS) plan&#xD;
&#xD;
          -  Have US mailing and email addresses&#xD;
&#xD;
          -  Cotinine saliva test results&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals who are found to have a prepaid cell phone&#xD;
&#xD;
          -  Individuals who are found to have a cellphone number that does not work or is&#xD;
             registered to someone else&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Contraindication for nicotine patch&#xD;
&#xD;
          -  Regular use of tobacco products other than cigarettes&#xD;
&#xD;
          -  Current use of tobacco cessation medications&#xD;
&#xD;
          -  Enrolled in another smoking cessation study&#xD;
&#xD;
          -  Non-English speakers&#xD;
&#xD;
          -  Having adequate equipment/device (webcam, speakers, mic) for participating in&#xD;
             telehealth sessions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Self-identified as a lesbian, gay, or bisexual individual</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Tami-Maury, DMD, MSc, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irene Tami-Maury, DMD, MSc, DrPH</last_name>
    <phone>(713) 500-9234</phone>
    <email>Irene.M.Tami-Maury@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Modupe Onigbogi</last_name>
    <phone>346-375-9819</phone>
    <email>Modupe.O.Onigbogi@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Irene Tami-Maury, DMD, MSc, DrPH</last_name>
      <phone>(713) 500-9234</phone>
      <email>Irene.M.Tami-Maury@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Modupe Onigbogi</last_name>
      <phone>346-375-9819</phone>
      <email>Modupe.O.Onigbogi@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 24, 2021</study_first_submitted>
  <study_first_submitted_qc>August 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Irene Tami-Maury</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>LGBTQI</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

